Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer
NCT01895790 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL
Last updated 2017-03-06
Summary
This research is being done to assess the effects of pancreatic duct stenting on relief of obstructive pain (pain due to outflow obstruction of main pancreatic duct) caused by pancreatic cancer.
Conditions
Interventions
- DEVICE
-
Pancreatic Duct Stent Placement
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Mouen Khashab, MD · Johns Hopkins Hospital Department of Gastroenterology
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain
NCT02578459 ·Status: WITHDRAWN ·Phase: NA
-
Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
NCT03080974 ·Status: RECRUITING ·Phase: PHASE2
-
A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer
NCT03707444 ·Status: WITHDRAWN
-
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
NCT00587132 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain
NCT00637364 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma
NCT05607953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
NCT00767273 ·Status: COMPLETED ·Phase: NA
-
Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma
NCT05955092 ·Status: UNKNOWN
-
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System
NCT02041936 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
NCT02902484 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Selective Transvenous Chemoembolization of Primary Pancreatic Tumors
NCT03865563 ·Status: WITHDRAWN ·Phase: PHASE1
-
Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer
NCT03117556 ·Status: WITHDRAWN ·Phase: NA
-
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
NCT00276744 ·Status: TERMINATED ·Phase: PHASE2
-
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
NCT04473794 ·Status: RECRUITING
-
Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues
NCT03544255 ·Status: UNKNOWN
-
Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
NCT02310971 ·Status: WITHDRAWN ·Phase: PHASE2
-
Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment
NCT04298242 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
NCT07254091 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
NCT04665947 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
NCT02869802 ·Status: RECRUITING
-
Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
NCT00660348 ·Status: TERMINATED ·Phase: NA
-
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
NCT05518903 ·Status: RECRUITING ·Phase: PHASE2
-
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
NCT01360593 ·Status: COMPLETED ·Phase: PHASE2
-
Pancreatic Enzyme Suppletion in Pancreatic Cancer
NCT01401387 ·Status: WITHDRAWN ·Phase: PHASE4
-
Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer
NCT01784081 ·Status: WITHDRAWN